Mark A. Hayden

808 total citations
10 papers, 300 citations indexed

About

Mark A. Hayden is a scholar working on Molecular Biology, Pharmacology and Obstetrics and Gynecology. According to data from OpenAlex, Mark A. Hayden has authored 10 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 1 paper in Pharmacology and 1 paper in Obstetrics and Gynecology. Recurrent topics in Mark A. Hayden's work include RNA and protein synthesis mechanisms (3 papers), Microbial Metabolic Engineering and Bioproduction (2 papers) and Innovative Microfluidic and Catalytic Techniques Innovation (1 paper). Mark A. Hayden is often cited by papers focused on RNA and protein synthesis mechanisms (3 papers), Microbial Metabolic Engineering and Bioproduction (2 papers) and Innovative Microfluidic and Catalytic Techniques Innovation (1 paper). Mark A. Hayden collaborates with scholars based in United States, Canada and United Kingdom. Mark A. Hayden's co-authors include Gary W. Ashley, Włodek Mandecki, Stephen D. Stroupe, David M. Kelso, Dirksen E. Bussiere, Sally M. McFall, Sujit R. Jangam, I.Y. Huang, Ralph M. Hecht and Michael Klass and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and The FASEB Journal.

In The Last Decade

Mark A. Hayden

9 papers receiving 289 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark A. Hayden United States 8 178 75 48 36 29 10 300
Peter D. Jeffrey Australia 12 228 1.3× 14 0.2× 16 0.3× 27 0.8× 43 1.5× 23 369
Lilian Chooback United States 12 204 1.1× 8 0.1× 50 1.0× 17 0.5× 68 2.3× 17 401
Erik Fiedler Germany 10 301 1.7× 29 0.4× 130 2.7× 36 1.0× 27 0.9× 16 470
Š. Toma Japan 7 216 1.2× 17 0.2× 48 1.0× 11 0.3× 18 0.6× 12 338
J Radik Australia 9 417 2.3× 11 0.1× 15 0.3× 95 2.6× 35 1.2× 9 517
Pedro M. F. Sousa Portugal 8 152 0.9× 8 0.1× 21 0.4× 24 0.7× 16 0.6× 15 193
Tateki Suzuki Japan 12 506 2.8× 9 0.1× 23 0.5× 50 1.4× 25 0.9× 19 611
Reginald McNulty United States 8 243 1.4× 28 0.4× 10 0.2× 20 0.6× 30 1.0× 13 375
Zsuzsanna Fekete Hungary 9 340 1.9× 9 0.1× 27 0.6× 15 0.4× 21 0.7× 17 518
Chris J. Bruton United Kingdom 8 338 1.9× 16 0.2× 29 0.6× 104 2.9× 60 2.1× 12 388

Countries citing papers authored by Mark A. Hayden

Since Specialization
Citations

This map shows the geographic impact of Mark A. Hayden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Hayden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Hayden more than expected).

Fields of papers citing papers by Mark A. Hayden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Hayden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Hayden. The network helps show where Mark A. Hayden may publish in the future.

Co-authorship network of co-authors of Mark A. Hayden

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Hayden. A scholar is included among the top collaborators of Mark A. Hayden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Hayden. Mark A. Hayden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Hayden, Mark A.. (2018). The Burgeoning “Biorights Movement”: Its Legal Basis, What’s at Stake, and How to Respond. Boston College law review. 59(5). 1775. 3 indexed citations
2.
Hayden, Mark A., Zehra Ordulu, C. Scott Gallagher, et al.. (2018). Clinical, pathologic, cytogenetic, and molecular profiling in self-identified black women with uterine leiomyomata. Cancer Genetics. 222-223. 1–8. 13 indexed citations
3.
Ordulu, Zehra, Mark A. Hayden, Masakazu Shinohara, et al.. (2015). From GWAS to Therapy: Fatty Acid Synthase in Uterine Leiomyomata. The FASEB Journal. 29(S1).
4.
McFall, Sally M., et al.. (2010). Immiscible Phase Nucleic Acid Purification Eliminates PCR Inhibitors with a Single Pass of Paramagnetic Particles through a Hydrophobic Liquid. Journal of Molecular Diagnostics. 12(5). 620–628. 80 indexed citations
5.
Colpitts, Tracey, Paula N. Friedman, Mark A. Hayden, et al.. (2001). Mammaglobin Is Found in Breast Tissue as a Complex with BU101. Biochemistry. 40(37). 11048–11059. 38 indexed citations
6.
Hayden, Mark A., et al.. (1993). Biosynthesis of lipoic acid: Characterization of the lipoic acid auxotrophs Escherichia coli W1485-lip2 and JRG33-lip9. Biochemistry. 32(14). 3778–3782. 40 indexed citations
7.
Hayden, Mark A., et al.. (1992). The biosynthesis of lipoic acid. Cloning of lip, a lipoate biosynthetic locus of Escherichia coli.. Journal of Biological Chemistry. 267(14). 9512–9515. 43 indexed citations
8.
Mandecki, Włodek, et al.. (1990). A totally synthetic plasmid for general cloning, gene expression and mutagenesis in Escherichia coli. Gene. 94(1). 103–107. 39 indexed citations
9.
Hayden, Mark A. & Włodek Mandecki. (1988). Gene Synthesis by Serial Cloning of Oligonucleotides. DNA. 7(8). 571–577. 13 indexed citations
10.
Hayden, Mark A., et al.. (1987). The glyceraldehyde-3-phosphate dehydrogenase gene family in the nematode, Caenorhabditis elegans: Isolation and characterization of one of the genes. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 908(1). 21–33. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026